National Institutes of Health Overview
- Investor Type
- Government
- Status
- Active
- Professionals
- 1
- Investments
- 1,790
- Portfolio
- 1,099
- Exits
- 228
National Institutes of Health General Information
Description
National Institutes of Health is a Government institute.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Government
Other Investor Types
Accelerator/Incubator
Primary Office
- 9000 Rockville Pike
- Bethesda, MD 20892
- United States
+1 (301) 000-0000
National Institutes of Health Investments (1,790)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Anavasi Diagnostics | 11-Nov-2021 | Grant | 000.00 | Diagnostic Equipment | Generating Revenue | |
| 00 000000000000 | 10-Nov-2021 | 00000 | 00.00 | Drug Discovery | Generating Revenue | |
| 000000000 | 01-Nov-2021 | 00000 | 00000 | Diagnostic Equipment | Startup | |
| 00000 | 19-Oct-2021 | 00000 | 00.00 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000000000 | 14-Oct-2021 | 00000 | 0000 | Other Healthcare Technology Systems | Startup | |
| 0000 000000 000000 | 06-Oct-2021 | 00000 | 00.00 | Therapeutic Devices | Generating Revenue | |
| 000000000 | 04-Oct-2021 | 00000 | 00.000 | Therapeutic Devices | Generating Revenue | |
| 00000000000 000000 | 04-Oct-2021 | 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| NuShores Biosciences | 04-Oct-2021 | Grant | 00.000 | Therapeutic Devices | Product Development | |
| Live Fully | 30-Sep-2021 | Grant | 00000 | Medical Supplies | Pre-Clinical Trials |
National Institutes of Health Exits (228)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Synabridge | 07-Mar-2022 | Out of Business | |
| 00000000 000000 00 | 21-Feb-2022 | 000000000000000000 | 00000 |
| 00000000000 000000 | 04-Feb-2022 | 000 00 00000000 | |
| 00000000 | 01-Feb-2022 | 000 00 00000000 | |
| 00000000 | 14-Jan-2022 | 000000000000000000 | |
| 00000 | 12-Jan-2022 | 000 00 00000000 | |
| 0000000 | 10-Jan-2022 | 000 00 00000000 | |
| 0000000000 | 30-Dec-2021 | 000 | 000.00 |
| Treyetech | 26-Dec-2021 | Out of Business | |
| NuPotential | 21-Dec-2021 | Out of Business |
National Institutes of Health Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNational Institutes of Health Team (13)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Shabestari Shabestari | Partner | 0 | Bethesda, MD | ||
| James Anderson Ph.D | Director of the Division & Deputy Director for Program Coordination, Planning and Strategic Initiatives | 0 | Bethesda, MD | ||
| Ahmed Hasan | Medical Officer & Program Director, NHLBI | 0 | Bethesda, MD | ||
| Francis Collins Ph.D | Director | 0 | Bethesda, MD | ||
| J.P. Kim | Program Manager & Extramural Data Sharing Policy Officer | 0 | Bethesda, MD |
National Institutes of Health Co-Investors (39)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| TEDCO | 2 |
|
|
||
| Citadel (Hedge Fund) | 0 |
|
|
||
| Eli Lilly | 0 | 0 |
|
|
|
| General Catalyst | 0 |
|
|
||
| Western Technology Investment | 0 |
|
|